TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today
that in celebration of its wholly-owned subsidiary FV Pharma Inc. having
been awarded a sales license by Health Canada, the company is hosting a
media event at its headquarters in Cobourg at 520 William St., a former
Kraft plant. Presenting at the event are the Company’s senior management
team members, local MP, Kim Rudd and Cobourg Mayor, John Henderson.
“Our company has received incredible support from the local community.
It is through this support that we were able to achieve this milestone,”
said President and Co-Founder Zeeshan Saeed. “The sales license is the
last step in our official entrance to the national cannabis market. This
allows us to accelerate investment in production, add jobs, and
contribute to the local economy in a meaningful and responsible way. We
are committed to Cobourg and the surrounding region and are confident
that we can find the employees we need from the local talent pool,”
added Saeed.
The company has committed publicly that it will be adding a number of
jobs over the next few years as it ramps up activities. Most of these
jobs will be sourced from the local talent pool.
“It is great to see an investment of this scale come to our community.
We know the hard work and diligence that FSD Pharma went through to get
to this point and I am confident that they will be a great corporate
citizen for this region for years to come,” said local Member of
Parliament, Kim Rudd.
Cobourg Mayor John Henderson, added, “We congratulate FSD Pharma for
this milestone achievement and welcome them and the opportunities they
will be creating for the community. Today the Town of Cobourg celebrates
with the company, and we look forward to being a partner in its
continued growth.”
FSD Pharma’s wholly-owned subsidiary, FV Pharma Inc., was awarded the
Sales License on April 18, 2019. The company had previously obtained its
cultivation license in October 2017, and its processing license in
February 2019. The Kraft facility was purchased by FSD Pharma in 2016.
About FSD Pharma
FSD Pharma is focused on the development of the highest quality indoor
grown, pharmaceutical grade cannabis and on the research and development
of novel cannabinoid-based treatments for several central nervous system
disorders, including chronic pain, fibromyalgia and irritable bowel
syndrome. The Company has 25,000 square feet available for production at
its Ontario facility.
FSD facilities sit on 70 acres of land with 40 acres primed for
development and an expansion capability of up to 3,896,000 square feet.
FSD’s wholly-owned subsidiary, FV Pharma, is a licensed producer under
the Cannabis Act and Regulations, having received its cultivation
license on October 13, 2017. FV Pharma’s vision is to transform its
current headquarters in a Kraft plant in Cobourg, Ontario into the
largest hydroponic indoor grow facility in the world. FV Pharma intends
to cover all aspects of this exciting new industry, including
cultivation, legal, processing, manufacturing, extracts and research and
development. For additional information on the company, please visit our
website at www.fsdpharma.com.
Contacts
Zeeshan Saeed, President, Founder and Director, FSD Pharma Inc.
Email:
zeeshan@fsdpharma.com,
Telephone: (416) 854-8884
Investor Relations: Email: ir@fsdpharma.com,
Website: www.fsdpharma.com
Media
Relations: Alex Fudukidis, Email: alex.fudukidis@russopartnersllc.com,
Tel.: (917) 436-8102